Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Therapix, University of Calgary to Evaluate Proprietary Drug Candidate for Pain

americanpharmaceuticalreviewDecember 24, 2020

Tag: Therapix , University of Calgary , THX-160 , Pain

PharmaSources Customer Service